Sachin Singh
Head Strategic Marketing,
DiaSys Diagnostics India Pvt. Ltd.

Way Forward

DiaSys is proud in celebrating 4 years of India operations. During this short journey, we made memorable and notable accomplishments in the backdrop of very challenging economic environment in our country. Upgrading manufacturing unit to spacious, state-of-the-art 2000 square meters Navi Mumbai premises in March 2017 shows our commitment for providing high quality indigenous products and in line with the Make in India initiative by the government. A major area of strength of DiaSys India is our effective sales and service network, which assures our customers that we shall continuously improve for satisfaction. We have a direct presence in all four poles of the country through four regional offices based at Delhi, Kolkata, Chennai, and Mumbai, which are supporting 100+ channel partners, and our staff counts now 180+ employees.

On one hand, DiaSys India has countless achievements and accomplishments, especially from last year, which proved to be exceptionally productive for the company: entire team and distributors across country have actively contributed to this progress. On the other hand, from the demand perspective, governmental policies and intent, increased health awareness have led to increase in preventive healthcare, screening, and check-ups, as well as enhanced treatment monitoring; in addition, reimbursements by insurance companies, increased wealth, increase in the seniority of the population, as well exponential jump in lifestyle related ailments have also contributed to the rise of the IVD industry.

DiaSys is following its mantra choosing quality to be a solution provider for quality products, systems and services! Our focus on understanding customer needs and demands, to create the best possible offering for them, has enabled us to gain acceptance and presence all over India at key institutions but also in rural places. Our emphasis on quality patient care, lab efficiency including turnaround times, workflow solutions, and improving the existing technologies has led to the development of a constant and futuristic improvement in our product range; as a matter of fact, we introduced this year in hematology with 3-part (respons r3H) and 5-part (respons r5H) differential hematology analyzer, innovative solutions for the Indian market.

DiaSys India is looking forward to accompany the growth of the IVD market in India; moving up segment in chemistry like introducing CLIA parameters on chemistry platform, hematology with launch of various products targeting mid high end customers. Also, DiaSys will offer specialized solutions, hence focusing on special parameters in top end hospitals and research universities. In addition, India is the hub for the DiaSys Group for R&D and manufacturing for PoC products – Make in India and export using the global network.

In our search for quality diagnostics, we take this opportunity to announce, among also other novelties, our new innovative solutions: Procalcitonin, first time in clinical chemistry. We are constantly focused on identifying new needs and new key parameters: quantified vitamin D, handheld urine ACR analyzer etc. Also, our R&D – in India – has made significant progress in PoCT device QDx Instalyte, novel electrolyte analyzer (all-in-one concept); with our technological advancements, we shall contribute to changing healthcare landscape.  In addition, the 67 key parameters of the Sys200/400 systems will be manufactured in India that will be a benefit to the end user using parameters in closed vials, therefore avoiding errors and thereby improving productivity. Through regular investments, employing skilled manpower and training systematically, we seek to accelerate the introduction of processes, technologies, and regulations required to continuously roll out high quality products from our Navi Mumbai manufacturing unit. Presently, we manufacture the key reagents relevant to the health of India in the segments of biochemistry, hematology, urine, and PoC.

The recently announced world’s biggest healthcare coverage policy Ayushman Bharat will be a milestone in the healthcare coverage. DiaSys India is preparing itself to be part of this initiative by the Government of India through its customers and leveraging the advantage of in house R&D and manufacturing set up. In all, DiaSys India is well poised for next level of growth in the one of the fastest growing economies of the world by leveraging the global experience to meet the local challenges.

Share this:
Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.